AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CLP1 | Cleavage and polyadenylation factor I subunit 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | | Expressed in all |
DDX5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EWSR1 | EWS RNA-binding protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FNBP1 | Formin binding protein 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
FOXP1 | Forkhead box P1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
FUBP1 | Far upstream element (FUSE) binding protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
FUS | Fused in sarcoma | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
GPHN | Gephyrin | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
HIP1 | Huntingtin interacting protein 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
HNRNPA2B1 | Heterogeneous nuclear ribonucleoprotein A2/B1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
LCK | Lymphocyte-specific protein tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
LCP1 | Lymphocyte cytosolic protein 1 (L-plastin) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
LPP | LIM domain containing preferred translocation partner in lipoma | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MITF | Microphthalmia-associated transcription factor | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MSN | Moesin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
NONO | Non-POU domain containing, octamer-binding | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
NPM1 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NUMA1 | Nuclear mitotic apparatus protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
PAFAH1B2 | Platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa) | Cancer-related genes Enzymes
| | | | | Expressed in all |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PICALM | Phosphatidylinositol binding clathrin assembly protein | Cancer-related genes Disease related genes
| | | | | Expressed in all |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PML | Promyelocytic leukemia | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PSIP1 | PC4 and SFRS1 interacting protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PTPRC | Protein tyrosine phosphatase, receptor type, C | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |